DK104116C - Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber. - Google Patents

Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.

Info

Publication number
DK104116C
DK104116C DK115259AA DK115259A DK104116C DK 104116 C DK104116 C DK 104116C DK 115259A A DK115259A A DK 115259AA DK 115259 A DK115259 A DK 115259A DK 104116 C DK104116 C DK 104116C
Authority
DK
Denmark
Prior art keywords
preparation
therapeutically active
appetite suppressant
suppressant properties
properties
Prior art date
Application number
DK115259AA
Other languages
Danish (da)
English (en)
Original Assignee
Wallace & Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US726010A external-priority patent/US2990332A/en
Priority claimed from US753093A external-priority patent/US3084099A/en
Application filed by Wallace & Tiernan Inc filed Critical Wallace & Tiernan Inc
Application granted granted Critical
Publication of DK104116C publication Critical patent/DK104116C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/03—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C205/04—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/08—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms
    • C07C205/09—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/14—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to acyclic carbon atoms
    • C07C205/16—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK115259AA 1958-04-02 1959-04-02 Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber. DK104116C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US726010A US2990332A (en) 1958-04-02 1958-04-02 Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US753093A US3084099A (en) 1958-08-04 1958-08-04 Therapeutic amine-resin complex composition and method of using same

Publications (1)

Publication Number Publication Date
DK104116C true DK104116C (da) 1966-04-04

Family

ID=27111252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115259AA DK104116C (da) 1958-04-02 1959-04-02 Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.

Country Status (6)

Country Link
BE (1) BE577279A (en:Method)
CH (1) CH391186A (en:Method)
DK (1) DK104116C (en:Method)
FR (1) FR465M (en:Method)
GB (1) GB916789A (en:Method)
NL (2) NL237722A (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467560A (en) * 1975-11-27 1977-03-16 Nicholas Int Ltd Preparation of ethylamine derivatives
DE68925933T2 (de) * 1988-08-12 1996-08-14 Fisons Corp Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung

Also Published As

Publication number Publication date
GB916789A (en) 1963-01-30
NL128079C (en:Method)
FR465M (en:Method) 1961-05-02
NL237722A (en:Method)
BE577279A (fr) 1959-10-01
CH391186A (de) 1965-04-30

Similar Documents

Publication Publication Date Title
DK104576C (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyrer.
DK102793C (da) Fremgangsmåde til fremstilling af et 4-halogen-2-butynyl-N-(3-halogenphenyl)-carbamat.
DK112379B (da) Fremgangsmåde til fremstilling af 16α-alkyl-20-keto-pregnan-enolacylater.
DK109089C (da) Fremgangsmåde til fremstilling af 5-nitrofuraner.
DK104116C (da) Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.
DK115542B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme α-dithiosemicarbazoner.
DK96184C (da) Fremgangsmåde til fremstilling af symmetriske bis-aminer.
DK95832C (da) Fremgangsmåde til fremstilling af 1- eller 7-aminoalkylxantinderivater.
DK91968C (da) Fremgangsmåde til fremstilling af 1-acylazetidiner.
DK92117C (da) Fremgangsmåde til fremstilling af 3-nitro-azacyklo-heptanon-2-N-karboklorid.
DK93398C (da) Fremgangsmåde til fremstilling af ethynylcarbinoler.
DK101525C (da) Fremgangsmåde til fremstilling af phenyloxymethyloxazolidinoner.
DK99081C (da) Fremgangsmåde til fremstilling af 16α-alkyl-20-keto-steroider.
DK96180C (da) Fremgangsmåde til fremstilling af dialkylenimider.
DK95680C (da) Fremgangsmåde til fremstilling af 3-cyanphentiazin.
DK95471C (da) Fremgangsmåde til fremstilling af sulfamylbenzamider.
DK95469C (da) Fremgangsmåde til fremstilling af sulfamylbenzamider.
DK92169C (da) Fremgangsmåde til fremstilling af ethyleniminoquinoner.
DK92118C (da) Fremgangsmåde til fremstilling af α-aminolaktamer.
DK91568C (da) Fremgangsmåde til fremstilling af 1-karbamylazetidiner.
DK100818C (da) Fremgangsmåde til fremstilling af 6-sulfamyl-4-quinazoloner.
DK91971C (da) Fremgangsmåde til fremstilling af threo-β-p-nitrophenylserin.
DK98688C (da) Fremgangsmåde til fremstilling af 6-desoxytetracycliner.
DK100110C (da) Fremgangsmåde til fremstilling af 2-cyan-3-oxo-steroider.
DK91320C (da) Fremgangsmåde til fremstilling af 1-monoacetyloleandomycin.